Literature DB >> 6951003

HLA-Dw2: a genetic marker for human immune response to short ragweed pollen allergen Ra5. I. Response resulting primarily from natural antigenic exposure.

D G Marsh, S H Hsu, M Roebber, E Ehrlich-Kautzky, L R Freidhoff, D A Meyers, M K Pollard, W B Bias.   

Abstract

Ultra-pure short ragweed pollen allergen Ra5 (5,000 mol wt) was used to investigate the relationship between human leukocyte antigen (HLA) type and IgE and IgG antibody (Ab) responses to Ra5 in two groups of Caucasian subjects, totaling 447 people. Using highly sensitive radioimmunoassay procedures to measure serum IgE and IgG Ab, qualitative responses to Ra5 in both groups were found to be strongly associated with HLA-Dw2 (P less than 0.0001). For example, 95% of 38 people with IgE Ab vs. 22% of 139 ragweed-allergic persons having no detectable IgE Ab to Ra5 were Dw2+. Quantitative log [IgE Ab] and log[IgG Ab] responses to Ra5 were highly correlated with Dw2 (P = 10(-5) to 10(-14)) in four separate multiple regression analyses, examining the relationship between HLA type (and other variables) and Ab levels in the two study groups. Further studies showed that the primary association of Ra5 response was with Dw2 rather than DR2 and that various combinations of A3, B7, and Dw2 were less strongly associated than Dw2 alone.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6951003      PMCID: PMC2186667          DOI: 10.1084/jem.155.5.1439

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  HLA-B7 cross-reacting group and human IgE-mediated sensitivity to ragweed allergen Ra5.

Authors:  L Goodfriend; J Santilli; B Schacter; W B Bias; D G Marsh
Journal:  Monogr Allergy       Date:  1977

2.  Capacity of purified antigens and whole pollen extracts to release histamine from leukocytes of hay fever patients.

Authors:  P S Norman; L M Lichtenstein
Journal:  J Allergy Clin Immunol       Date:  1973-08       Impact factor: 10.793

3.  Diagnostic tests in ragweed hay fever. A comparison of direct skin tests, IgE antibody measurements, and basophil histamine release.

Authors:  P S Norman; L M Lichtenstein; K Ishizaka
Journal:  J Allergy Clin Immunol       Date:  1973-10       Impact factor: 10.793

4.  Association of the HL-A7 cross-reacting group with a specific reaginic antibody response in allergic man.

Authors:  D G Marsh; W B Bias; S H Hsu; L Goodfriend
Journal:  Science       Date:  1973-02-16       Impact factor: 47.728

5.  An improved procedure for isolation of ragweed pollen allergen Ra5.

Authors:  M Roebber; D G Marsh; L Goodfriend
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

6.  Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants.

Authors:  J J van Rood; A van Leeuwen; J S Ploem
Journal:  Nature       Date:  1976-08-26       Impact factor: 49.962

7.  Isolation of a low molecular weight ragweed pollen allergen: Ra5.

Authors:  C B Lapkoff; L Goodfriend
Journal:  Int Arch Allergy Appl Immunol       Date:  1974

8.  Ragweed allergen Ra5: a new tool in understanding the genetics and immunochemistry of immune response in man.

Authors:  D G Marsh; W B Bias; J Santilli; B Schacter; L Goodfriend
Journal:  Immunochemistry       Date:  1975-07

9.  The amino acid sequence of ragweed pollen allergen Ra5.

Authors:  L E Mole; L Goodfriend; C B Lapkoff; J M Kehoe; J D Capra
Journal:  Biochemistry       Date:  1975-03-25       Impact factor: 3.162

10.  Measurement of absolute amounts of antigen-specific human IgE by a radioallergosorbent test (RAST) elution technique.

Authors:  R R Schellenberg; N F Adkinson
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

View more
  30 in total

Review 1.  Prediction of the development of IgE-mediated atopic disorders and environmental engineering for their control.

Authors:  B A Chowdhury; R K Chandra
Journal:  Clin Rev Allergy       Date:  1989

Review 2.  Risk factors for the development of food allergy.

Authors:  Ujwala Kaza; Adina Kay Knight; Sami L Bahna
Journal:  Curr Allergy Asthma Rep       Date:  2007-06       Impact factor: 4.806

3.  Candidate gene loci in asthmatic and allergic inflammation.

Authors:  J Wilkinson; S T Holgate
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

4.  Effect of cytokines on spontaneous and allergen-induced CD23 expression, sCD23 release and Ig(E,G) synthesis from peripheral blood lymphocytes.

Authors:  T Pfeil; A Fischer; J Bujanowski-Weber; H Luther; P Altmeyer; W König
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

5.  Immune response gene control of the murine antibody response to the phospholipase A2 of honey bee venom.

Authors:  A Lucas; R N Hamburger
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

Review 6.  Genetic control of IgE immune response.

Authors:  S Matsushita; T Sasazuki
Journal:  Clin Rev Allergy       Date:  1989

Review 7.  Are specific allergen sensitivities inherited?

Authors:  Rana Tawil Misiak; Ganesa Wegienka; Edward Zoratti
Journal:  Curr Allergy Asthma Rep       Date:  2010-09       Impact factor: 4.806

8.  In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.

Authors:  D L Mann; N Mendell; C R Kahn; A H Johnson; A Rosenthal
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

9.  N-terminal amino acid sequence identity between a major allergen of Ascaris lumbricoides and Ascaris suum, and MHC-restricted IgE responses to it.

Authors:  J F Christie; B Dunbar; I Davidson; M W Kennedy
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

10.  Specific allergic sensitization in parents and their 18-year-old offspring in the Suburban Detroit Childhood Allergy Study.

Authors:  Rana Tawil Misiak; Ganesa Wegienka; Suzanne Havstad; Dennis R Ownby; Christine Cole Johnson; Edward M Zoratti
Journal:  J Allergy Clin Immunol       Date:  2009-05-05       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.